Daicel Pharma Standards is a global provider of high-quality pharmaceutical reference standards and custom synthesis solutions, supporting pharmaceutical and biotechnology companies across the entire drug development lifecycle. The company specializes in the synthesis and supply of certified impurity standards, stable isotope-labelled compounds, drug metabolites, and reference materials that are critical for impurity profiling, analytical method validation, regulatory compliance, and bioanalytical studies.
With headquarters in Hyderabad, India, Daicel Pharma Standards maintains an extensive ready-to-ship catalogue of small-molecule impurity standards, labeled standards (including stable isotopes such as ^2H and ^13C), nitrosamine (NDSRI) standards, peptide and oligonucleotide impurity standards, and extractables & leachables (E & L) reference materials. These products are supplied at scales ranging from milligrams to multi-grams and are designed to support regulatory filing requirements and analytical accuracy.
